Formyl Peptide Receptor 1 Inhibits Reparative Angiogenesis and Aggravates Neuroretinal Dysfunction in Ischemic...

Area of Science:

• Ophthalmology
• Immunology
• Vascular Biology

Background:

• Ischemic retinopathy is a leading cause of vision loss.
• Inflammation is a key factor in ischemic retinopathy development.
• Formyl peptide receptor 1 (FPR1) is involved in inflammatory disorders, but its role in ischemic retinopathy is unclear.

Purpose of the Study:

• To investigate the role of FPR1 in the progression of ischemic retinopathy.
• To determine how FPR1 influences inflammatory responses and angiogenesis in the ischemic retina.

Main Methods:

• Real-time PCR and western blotting to measure FPR1 activation in oxygen-induced retinopathy (OIR) models.
• Assessment of inflammatory cytokines and pro-angiogenic factors in wild-type and FPR1-deficient OIR mice.
• Evaluation of retinal neovascularization and vaso-obliteration.
• Electroretinography (ERG) to assess retinal neural function.

Main Results:

• FPR1 expression was significantly elevated in the retinas of OIR mice.
• FPR1 deficiency led to reduced expression of pro-inflammatory and pro-angiogenic factors.
• Ablation of FPR1 suppressed pathological neovascularization and promoted reparative revascularization.
• FPR1 deficiency improved retinal neural function after ischemic injury.

Conclusions:

• FPR1 plays a detrimental role in ischemic retinopathy by promoting inflammation and inhibiting reparative angiogenesis.
• Targeting FPR1 may be a potential therapeutic strategy to mitigate neuronal dysfunction and improve outcomes in ischemic retinopathy.